Jared Rex Robbins
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jared Rex Robbins has a total of 299 co-authors. Here are the top co-authors by number of shared publications:
- Mohamed A. Elshaikh
Department of Radiation Oncology, Henry Ford Health, Detroit, MI 48202, USA
5 shared publications - Alexandre Alarcon Steiner
Departamento de Imunologia, Instituto de Ciencias Biomedicas, Universidade de Sao Paulo, Sao Paulo, SP 05508-000, Brazil
4 shared publications Meredith Mahan
Biostatistics, Henry Ford Health System, Detroit, MI
4 shared publicationsMohamed A. Elshaikh
4 shared publicationsRaphael Yechieli
4 shared publications- X. Allen Li
Department of Radiation Oncology Medical College of Wisconsin Milwaukee Wisconsin USA
4 shared publications
Latest Publications
- Open Access
- 27 October 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (11) , 647
Beyond Prescription Dose: Implant-Site Radiation Dosimetry and Clinical Outcomes of Dental Implants Placed After Head and Neck Radiotherapy—A Systematic Review and Proposed Dosimetric Framework
Background: Dental implants can improve oral rehabilitation following head and neck radiotherapy (RT). The relationship between radiation dose and implant outcomes is not well defined, because specific radiation doses at the implant site are inconsistently reported. Methods: This systematic review evaluated dental implants placed after head and neck RT to determine the impact of the level of radiation dose reporting on outcomes. Studies were assessed for the quality of the reported radiation dosimetry, implant survival, and osteoradionecrosis (ORN). Radiation reporting was classified using a five-level hierarchy ranging from implant-site-specific dosimetry (Level I) to no dose information (Level V). Results: Forty-eight studies met inclusion criteria. Implant-site data (Levels I–II) were reported in 50 Gy and even higher risks above 60 Gy. Conclusions: Dental implantation after head and neck RT can achieve favorable outcomes, but most studies are limited by inadequate evaluation of implant-site radiation dose. Studies evaluating IS radiation dose provide important insights into risk-assessment and implant outcomes. Future studies should report implant-site dose in prospective studies in order to assess and validate useful dose–response thresholds.
- 27 October 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (11) , 647
Open AccessBeyond Prescription Dose: Implant-Site Radiation Dosimetry and Clinical Outcomes of Dental Implants Placed After Head and Neck Radiotherapy—A Systematic Review and Proposed Dosimetric Framework
Background: Dental implants can improve oral rehabilitation following head and neck radiotherapy (RT). The relationship between radiation dose and implant outcomes is not well defined, because specific radiation doses at the implant site are inconsistently reported. Methods: This systematic review evaluated dental implants placed after head and neck RT to determine the impact of the level of radiation dose reporting on outcomes. Studies were assessed for the quality of the reported radiation dosimetry, implant survival, and osteoradionecrosis (ORN). Radiation reporting was classified using a five-level hierarchy ranging from implant-site-specific dosimetry (Level I) to no dose information (Level V). Results: Forty-eight studies met inclusion criteria. Implant-site data (Levels I–II) were reported in 50 Gy and even higher risks above 60 Gy. Conclusions: Dental implantation after head and neck RT can achieve favorable outcomes, but most studies are limited by inadequate evaluation of implant-site radiation dose. Studies evaluating IS radiation dose provide important insights into risk-assessment and implant outcomes. Future studies should report implant-site dose in prospective studies in order to assess and validate useful dose–response thresholds.
- Open Access
- 1 September 2026
- Published by AME Publishing Company in Annals of Palliative Medicine
- Vol. 15 (5) , 71
Assessing palliative care education and attitudes among radiation oncology residents
Background: Palliative care (PC) plays a vital role in radiation oncology (RO), but the breadth, quality, and effectiveness of formal PC education and radiation-specific palliative care (RSPC) during residency vary widely. A better understanding of how RO residents view their current training and where they see room for improvement can help guide future educational efforts. The study aims to evaluate RO residents’ experiences with and attitudes toward PC and RSPC education, identify perceived gaps in training, gather suggestions for important topics, and determine preferred ways to optimally incorporate PC teaching into the existing resident schedule framework. Methods: From January through May 2025, a national cross-sectional survey was sent to 552 PGY-3 to PGY-5 U.S. RO residents using a REDCap-based online platform. The anonymous survey collected demographic information and inquired about the adequacy of current PC education, areas of additional instruction, and preferred learning formats and scheduling. Quantitative data were summarized descriptively, and mapped to the corresponding structured categories where relevant. Results: A total of 110 responses were received (response rate 19.9%). Most respondents identified as White (60.9%) and male (65.4%) from programs with 5–9 (40.7%) or 10–14 (35.2%) residents. While 89.0% reported access to a dedicated PC specialist, only 27.5% reported access to an RSPC specialist. Nearly all respondents supported the need for formal training in RSPC (96.0%) and general PC (84.2%). Although 45.5% reported faculty-led instruction in PC or RSPC, 15.8% indicated receiving no formal training in either area. Topics of greatest interest included symptom management, hospice care, ethical issues for PC, spinal stereotactic body radiation therapy (SBRT), and on-call management for RSPC. Residents preferred case-based, quarterly modules lasting 30–60 minutes as the most feasible educational format. Conclusions: RO residents widely recognize the importance of structured PC and RSPC training but report significant variability in current educational offerings. Programs may enhance preparedness and patient care by integrating concise, case-based, and specialty-relevant PC content into existing curricula. These findings highlight the need for standardized national efforts to strengthen PC education within RO training.
- 1 September 2026
- Published by AME Publishing Company in Annals of Palliative Medicine
- Vol. 15 (5) , 71
Open AccessAssessing palliative care education and attitudes among radiation oncology residents
Background: Palliative care (PC) plays a vital role in radiation oncology (RO), but the breadth, quality, and effectiveness of formal PC education and radiation-specific palliative care (RSPC) during residency vary widely. A better understanding of how RO residents view their current training and where they see room for improvement can help guide future educational efforts. The study aims to evaluate RO residents’ experiences with and attitudes toward PC and RSPC education, identify perceived gaps in training, gather suggestions for important topics, and determine preferred ways to optimally incorporate PC teaching into the existing resident schedule framework. Methods: From January through May 2025, a national cross-sectional survey was sent to 552 PGY-3 to PGY-5 U.S. RO residents using a REDCap-based online platform. The anonymous survey collected demographic information and inquired about the adequacy of current PC education, areas of additional instruction, and preferred learning formats and scheduling. Quantitative data were summarized descriptively, and mapped to the corresponding structured categories where relevant. Results: A total of 110 responses were received (response rate 19.9%). Most respondents identified as White (60.9%) and male (65.4%) from programs with 5–9 (40.7%) or 10–14 (35.2%) residents. While 89.0% reported access to a dedicated PC specialist, only 27.5% reported access to an RSPC specialist. Nearly all respondents supported the need for formal training in RSPC (96.0%) and general PC (84.2%). Although 45.5% reported faculty-led instruction in PC or RSPC, 15.8% indicated receiving no formal training in either area. Topics of greatest interest included symptom management, hospice care, ethical issues for PC, spinal stereotactic body radiation therapy (SBRT), and on-call management for RSPC. Residents preferred case-based, quarterly modules lasting 30–60 minutes as the most feasible educational format. Conclusions: RO residents widely recognize the importance of structured PC and RSPC training but report significant variability in current educational offerings. Programs may enhance preparedness and patient care by integrating concise, case-based, and specialty-relevant PC content into existing curricula. These findings highlight the need for standardized national efforts to strengthen PC education within RO training.
- 2 July 2026
- Published by Springer Nature
- p. 47-60
Multi-phase Mandible-Anchored Automated Segmentation of Oropharyngeal GTVs in FDG-PET/CT
- 2 July 2026
- Published by Springer Nature
- p. 47-60
Multi-phase Mandible-Anchored Automated Segmentation of Oropharyngeal GTVs in FDG-PET/CT
- Open Access
Simultaneous Versus Sequential IMRT Boost in the Era of Treatment De-Escalation of Head and Neck Cancers
Radiation therapy is a central component of the definitive and postoperative management for head and neck cancers (HNC), with intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) now standard. Within these techniques, two principal boost strategies are used: simultaneous integrated boost (SIB) and sequential boost (SEQ). Although both are guideline-supported, they differ in planning logistics, treatment delivery, potential radiobiologic effects, adaptability to anatomic change, and potential toxicity profiles. In this narrative review, we summarize the key technical, dosimetric, and radiobiologic differences between SIB and SEQ and synthesize the available comparative clinical data, with a focus on their roles in contemporary dose de-escalation strategies. SIB allows for differential dosing within a single plan and potentially shorter overall treatment time but typically delivers higher biologically effective doses (BED) to elective nodal regions. SEQ requires two plans but offers greater flexibility for adaptive replanning, facilitates a lower BED to elective nodal volumes, and may allow for partial normal tissue recovery during the boost phase. Comparative studies, including retrospective series, randomized trials, and a meta-analysis, have not demonstrated consistent differences between SIB and SEQ in survival or local control, with mixed findings regarding toxicity. In the context of de-escalation, multiple prospective studies have successfully used SEQ to reduce elective nodal dose with low rates of elective nodal failure, while recent data suggest that SIB-based elective dose reduction may also be feasible in select settings. Overall, both SIB and SEQ are effective boost strategies in HNC radiotherapy. While practice is often driven by institutional workflow and clinician preference, emerging evidence suggests potential advantages of SEQ for elective nodal dose de-escalation. Further prospective studies are needed to better define the relative impacts of SIB and SEQ on toxicity and tumor control.
Open AccessSimultaneous Versus Sequential IMRT Boost in the Era of Treatment De-Escalation of Head and Neck Cancers
Radiation therapy is a central component of the definitive and postoperative management for head and neck cancers (HNC), with intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) now standard. Within these techniques, two principal boost strategies are used: simultaneous integrated boost (SIB) and sequential boost (SEQ). Although both are guideline-supported, they differ in planning logistics, treatment delivery, potential radiobiologic effects, adaptability to anatomic change, and potential toxicity profiles. In this narrative review, we summarize the key technical, dosimetric, and radiobiologic differences between SIB and SEQ and synthesize the available comparative clinical data, with a focus on their roles in contemporary dose de-escalation strategies. SIB allows for differential dosing within a single plan and potentially shorter overall treatment time but typically delivers higher biologically effective doses (BED) to elective nodal regions. SEQ requires two plans but offers greater flexibility for adaptive replanning, facilitates a lower BED to elective nodal volumes, and may allow for partial normal tissue recovery during the boost phase. Comparative studies, including retrospective series, randomized trials, and a meta-analysis, have not demonstrated consistent differences between SIB and SEQ in survival or local control, with mixed findings regarding toxicity. In the context of de-escalation, multiple prospective studies have successfully used SEQ to reduce elective nodal dose with low rates of elective nodal failure, while recent data suggest that SIB-based elective dose reduction may also be feasible in select settings. Overall, both SIB and SEQ are effective boost strategies in HNC radiotherapy. While practice is often driven by institutional workflow and clinician preference, emerging evidence suggests potential advantages of SEQ for elective nodal dose de-escalation. Further prospective studies are needed to better define the relative impacts of SIB and SEQ on toxicity and tumor control.
- Open Access
- 10 April 2026
- Published by Springer Nature in Cureus
- Vol. 18 (4)
Barriers, Perceptions, and Predictors for Utilizing Health-Related Technology Among Individuals Receiving Radiation Oncology Care
Introduction: For many people, mobile applications are pivotal to their daily lives. With a constantly increasing number of applications, the utilization of mobile health (mHealth) has augmented various aspects of clinical care outside of traditional clinical appointments, such as patient communication and monitoring. Despite these advancements, widespread adoption of these applications by cancer patients remains limited. This study aims to evaluate radiation oncology patients’ access to technology resources and evaluate the impact of the COVID-19 pandemic on willingness to engage in mHealth.
- 10 April 2026
- Published by Springer Nature in Cureus
- Vol. 18 (4)
Open AccessBarriers, Perceptions, and Predictors for Utilizing Health-Related Technology Among Individuals Receiving Radiation Oncology Care
Introduction: For many people, mobile applications are pivotal to their daily lives. With a constantly increasing number of applications, the utilization of mobile health (mHealth) has augmented various aspects of clinical care outside of traditional clinical appointments, such as patient communication and monitoring. Despite these advancements, widespread adoption of these applications by cancer patients remains limited. This study aims to evaluate radiation oncology patients’ access to technology resources and evaluate the impact of the COVID-19 pandemic on willingness to engage in mHealth.
- Open Access
- 30 June 2025
- Published by Korean Society for Therapeutic Radiology and Oncology in Radiation Oncology Journal
- Vol. 43 (2) , 63-72
Dosimetric analysis of different whole brain radiotherapy treatment planning methods: three types of 3-dimensional versus hippocampal avoidant
Purpose: Our purpose was to compare four whole brain radiotherapy (WBRT) delivery types: opposed lateral (OL) 3-dimensional-conformal radiotherapy (3D-CRT), a novel opposed lateral sparing (OLS) 3D-CRT technique, 3D optimized dynamic conformal arcs (optDCA), and hippocampal-avoidant WBRT (HA-WBRT).Materials and Methods: Ten patients previously undergoing HA-WBRT were retrospectively planned using OL, OLS, and optDCA techniques. OLS technique involved multi-leaf collimator (MLC) modifications to protect the lacrimal and parotid glands. OptDCA was inverse-planned 3D-CRT with dynamic conformal arcs. A dosimetric, cost, and resource utilization comparison was performed.Results: Planning target volume coverage to prescription dose between 3D planning techniques was not significantly different between OL and OLS techniques (96.8% vs. 96.6%, p = 0.855), or between OL, OLS, and optDCA (95.0%) techniques (p = 0.079). There was no difference in the heterogeneity index between 3D plans (p = 0.482); all were less heterogeneous than HA-WBRT (p < 0.001). OptDCA was more conformal than OL and OLS, and similar in conformity to HA-WBRT. OLS achieved significant sparing of lacrimal and parotid glands over OL. There were significant step-function reductions in organ at risk (OAR) dose when comparing OL to OLS to optDCA to HA-WBRT plans. HA-WBRT was 57% more expensive than OL and OLS technique. HA-WBRT took approximately six times longer to plan.Conclusion: We showed adequate and equivalent target coverage using OL, OLS, and optDCA techniques. Lacrimal and parotid dosages can be greatly reduced with the implementation of minor MLC adjustments. OptDCA therapy represented further improvement of these modifications, and was comparable to HA-WBRT in terms of OAR dose, while being about two-thirds the cost and more efficient to plan.
- 30 June 2025
- Published by Korean Society for Therapeutic Radiology and Oncology in Radiation Oncology Journal
- Vol. 43 (2) , 63-72
Open AccessDosimetric analysis of different whole brain radiotherapy treatment planning methods: three types of 3-dimensional versus hippocampal avoidant
Purpose: Our purpose was to compare four whole brain radiotherapy (WBRT) delivery types: opposed lateral (OL) 3-dimensional-conformal radiotherapy (3D-CRT), a novel opposed lateral sparing (OLS) 3D-CRT technique, 3D optimized dynamic conformal arcs (optDCA), and hippocampal-avoidant WBRT (HA-WBRT).Materials and Methods: Ten patients previously undergoing HA-WBRT were retrospectively planned using OL, OLS, and optDCA techniques. OLS technique involved multi-leaf collimator (MLC) modifications to protect the lacrimal and parotid glands. OptDCA was inverse-planned 3D-CRT with dynamic conformal arcs. A dosimetric, cost, and resource utilization comparison was performed.Results: Planning target volume coverage to prescription dose between 3D planning techniques was not significantly different between OL and OLS techniques (96.8% vs. 96.6%, p = 0.855), or between OL, OLS, and optDCA (95.0%) techniques (p = 0.079). There was no difference in the heterogeneity index between 3D plans (p = 0.482); all were less heterogeneous than HA-WBRT (p < 0.001). OptDCA was more conformal than OL and OLS, and similar in conformity to HA-WBRT. OLS achieved significant sparing of lacrimal and parotid glands over OL. There were significant step-function reductions in organ at risk (OAR) dose when comparing OL to OLS to optDCA to HA-WBRT plans. HA-WBRT was 57% more expensive than OL and OLS technique. HA-WBRT took approximately six times longer to plan.Conclusion: We showed adequate and equivalent target coverage using OL, OLS, and optDCA techniques. Lacrimal and parotid dosages can be greatly reduced with the implementation of minor MLC adjustments. OptDCA therapy represented further improvement of these modifications, and was comparable to HA-WBRT in terms of OAR dose, while being about two-thirds the cost and more efficient to plan.
- Open Access
- 1 May 2025
- Published by AME Publishing Company in Annals of Palliative Medicine
- Vol. 14 (3) , 247-254
Palliative radiation oncology programs: improving value through high-quality and cost-effective care
An estimated 40% of all radiation treatments are delivered with non-curative intent, and there is strong evidence that this cohort of patients benefits from the early integration of palliative care services. Palliative radiation oncology programs (PROPs) are teams, processes, or systems that were developed to meet these needs. PROPs address specific issues related to the delivery of palliative radiation therapy (PRT) and try to enhance and improve the quality, cost, timeliness, and value of patient care. While PROPs can be tailored to specifically meet any institutional needs, establishing a sustainable PROP requires commitment from the institution, the systemic integration of standardized care pathways, workflows, and best practice guidelines, collaboration within the oncology team, and dedicated infrastructure resources. PROPs have been shown to improve timely access to care, increase patient and provider satisfaction, advance guideline-concordant care, standardize assessment of palliative care needs, improve palliative care education among radiation oncology residents, and reduce hospital stays and health care costs. While not yet widely adopted, the benefits they provide confirm their value and importance for patients with advanced cancer and for the health care system in general. This article outlines the reasons PROPs were developed, discusses elements related to developing sustainable PROPs, and highlights the value that they provide while reducing costs.
- 1 May 2025
- Published by AME Publishing Company in Annals of Palliative Medicine
- Vol. 14 (3) , 247-254
Open AccessPalliative radiation oncology programs: improving value through high-quality and cost-effective care
An estimated 40% of all radiation treatments are delivered with non-curative intent, and there is strong evidence that this cohort of patients benefits from the early integration of palliative care services. Palliative radiation oncology programs (PROPs) are teams, processes, or systems that were developed to meet these needs. PROPs address specific issues related to the delivery of palliative radiation therapy (PRT) and try to enhance and improve the quality, cost, timeliness, and value of patient care. While PROPs can be tailored to specifically meet any institutional needs, establishing a sustainable PROP requires commitment from the institution, the systemic integration of standardized care pathways, workflows, and best practice guidelines, collaboration within the oncology team, and dedicated infrastructure resources. PROPs have been shown to improve timely access to care, increase patient and provider satisfaction, advance guideline-concordant care, standardize assessment of palliative care needs, improve palliative care education among radiation oncology residents, and reduce hospital stays and health care costs. While not yet widely adopted, the benefits they provide confirm their value and importance for patients with advanced cancer and for the health care system in general. This article outlines the reasons PROPs were developed, discusses elements related to developing sustainable PROPs, and highlights the value that they provide while reducing costs.
- Open Access
- 31 March 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1432916
Implications of primary tumor site and fraction size on outcomes of palliative radiation for osseous metastases
Purpose: This study reviewed palliative radiation therapy (RT) practices and outcomes and compared the percentage of remaining life spent receiving RT (PRLSRT) in patients treated for osseous metastases.Methods: A retrospective analysis was conducted using the National Cancer Database (2010–2016) to evaluate metastatic patients who received palliative bone RT. Common palliative RT schemes were analyzed to determine treatment patterns and outcomes. Palliative outcomes, including median PRLSRT, RT completion, and mortality rates, were calculated. Binary logistic regression was performed to identify factors affecting RT completion, and a scoring system was developed to identify patients at risk for poor palliative outcomes.Results: A total of 50,929 patients were included, with the majority diagnosed with NSCLC (45.2%), breast cancer (15.1%), or prostate cancer (10.8%). The median overall survival after palliative RT was 5.74 months. Patients receiving lower doses per fraction (2.5 Gy/Fx) tended to be younger, healthier, and yet experienced worse palliative outcomes. Binary logistic regression identified age, race, income quartile, and Gy/Fx as significant factors affecting RT completion. Median PRLSRTs were as follows: 14.95% for GI NOS, 9.89% for upper GI, 9.46% for NSCLC, 8.67% for skin, 7.06% for SCLC, 6.10% for lower GI, 5.59% for GYN, 5.44% for GU, 5.35% for HNC, 2.05% for endocrine, 2.03% for prostate cancer, and 1.82% for breast cancer. Patients receiving 2.5 and 3 Gy/Fx were less likely to complete RT compared to those receiving 4 Gy/Fx (OR, 1.429 and 3.780, respectively; p < 0.001). Age, comorbidities, primary tumor, target location, and metastatic burden were associated with PRLSRT ≥ 25%.Conclusion: Dose regimens and patient selection influence palliative bone RT outcomes. Both factors should be carefully considered to minimize the burden of care and maximize treatment benefits.
- 31 March 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1432916
Open AccessImplications of primary tumor site and fraction size on outcomes of palliative radiation for osseous metastases
Purpose: This study reviewed palliative radiation therapy (RT) practices and outcomes and compared the percentage of remaining life spent receiving RT (PRLSRT) in patients treated for osseous metastases.Methods: A retrospective analysis was conducted using the National Cancer Database (2010–2016) to evaluate metastatic patients who received palliative bone RT. Common palliative RT schemes were analyzed to determine treatment patterns and outcomes. Palliative outcomes, including median PRLSRT, RT completion, and mortality rates, were calculated. Binary logistic regression was performed to identify factors affecting RT completion, and a scoring system was developed to identify patients at risk for poor palliative outcomes.Results: A total of 50,929 patients were included, with the majority diagnosed with NSCLC (45.2%), breast cancer (15.1%), or prostate cancer (10.8%). The median overall survival after palliative RT was 5.74 months. Patients receiving lower doses per fraction (2.5 Gy/Fx) tended to be younger, healthier, and yet experienced worse palliative outcomes. Binary logistic regression identified age, race, income quartile, and Gy/Fx as significant factors affecting RT completion. Median PRLSRTs were as follows: 14.95% for GI NOS, 9.89% for upper GI, 9.46% for NSCLC, 8.67% for skin, 7.06% for SCLC, 6.10% for lower GI, 5.59% for GYN, 5.44% for GU, 5.35% for HNC, 2.05% for endocrine, 2.03% for prostate cancer, and 1.82% for breast cancer. Patients receiving 2.5 and 3 Gy/Fx were less likely to complete RT compared to those receiving 4 Gy/Fx (OR, 1.429 and 3.780, respectively; p < 0.001). Age, comorbidities, primary tumor, target location, and metastatic burden were associated with PRLSRT ≥ 25%.Conclusion: Dose regimens and patient selection influence palliative bone RT outcomes. Both factors should be carefully considered to minimize the burden of care and maximize treatment benefits.